These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15107989)

  • 21. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
    Sánchez-Tacuba L; Rojas M; Arias CF; López S
    J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells.
    Banerjee S; An S; Zhou A; Silverman RH; Makino S
    J Virol; 2000 Oct; 74(19):8793-802. PubMed ID: 10982321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
    Anderson BR; Muramatsu H; Jha BK; Silverman RH; Weissman D; Karikó K
    Nucleic Acids Res; 2011 Nov; 39(21):9329-38. PubMed ID: 21813458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people.
    Fabre O; Breuker C; Amouzou C; Salehzada T; Kitzmann M; Mercier J; Bisbal C
    Cell Death Dis; 2014 Mar; 5(3):e1136. PubMed ID: 24651439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
    Malathi K; Dong B; Gale M; Silverman RH
    Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
    Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
    Han JQ; Townsend HL; Jha BK; Paranjape JM; Silverman RH; Barton DJ
    J Virol; 2007 Jun; 81(11):5561-72. PubMed ID: 17344297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
    Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
    Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An apoptotic pathway of 3'-Ethynylcytidine(ECyd) involving the inhibition of RNA synthesis mediated by RNase L.
    Naito T; Yokogawa T; Kim HS; Matsuda A; Sasaki T; Fukushima M; Kitade Y; Wataya Y
    Nucleic Acids Symp Ser (Oxf); 2006; (50):103-4. PubMed ID: 17150838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus.
    Cohrs RJ; Condit RC; Pacha RF; Thompson CL; Sharma OK
    J Virol; 1989 Feb; 63(2):948-51. PubMed ID: 2911126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCE1 Acts as a Positive Regulator of Exogenous RNA Decay.
    Nogimori T; Ogami K; Oishi Y; Goda R; Hosoda N; Kitamura Y; Kitade Y; Hoshino SI
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32033097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation.
    Smith JA; Schmechel SC; Williams BR; Silverman RH; Schiff LA
    J Virol; 2005 Feb; 79(4):2240-50. PubMed ID: 15681426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
    Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
    RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNase L targets distinct sites in influenza A virus RNAs.
    Cooper DA; Banerjee S; Chakrabarti A; García-Sastre A; Hesselberth JR; Silverman RH; Barton DJ
    J Virol; 2015 Mar; 89(5):2764-76. PubMed ID: 25540362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.
    Malathi K; Siddiqui MA; Dayal S; Naji M; Ezelle HJ; Zeng C; Zhou A; Hassel BA
    mBio; 2014 Oct; 5(6):e02012. PubMed ID: 25352621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.
    Khabar KS; Dhalla M; Siddiqui Y; Zhou A; Al-Ahdal MN; Der SD; Silverman RH; Williams BR
    J Interferon Cytokine Res; 2000 Jul; 20(7):653-9. PubMed ID: 10926208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.